Evolva Q1 2021 Trading Update
Evolva Holding SA / Key word(s): Miscellaneous
Reinach, April 21, 2021 - Evolva (SIX:EVE) today issues a trading update in respect to the period from January to March 2021.
Sales continued to progress well, with the trends and momentum described in our FY 2020 results on 25 February 2021. We are seeing a particularly strong performance in Health Ingredients driven by consumer trends, and weaker demand in Flavors and Fragrances, which is still impacted by the pandemic but with promising signs of recovery. Overall trading continues in line with our expectations.
We have made progress in scaling up and running manufacturing, with steady delivery of volumes of key products, which backed growth during the first quarter of the year. We are now in the process of further increasing capacity in our network of contract manufacturers. This will start to support our business in the second half of the year, in line with plans.
Oliver Walker, CEO of Evolva, said: «It would not be appropriate in the present pandemic to say that we look forward to the future with confidence, but we are in a favourable position. I remain grateful and proud of our people for their commitment and continued support from our customers.»
For Evolva multimedia content, please visit: evolva.com/multimedia-library/.
End of ad hoc announcement
|Company:||Evolva Holding SA|
|Phone:||+41 61 485 20 00|
|Listed:||SIX Swiss Exchange|
|EQS News ID:||1186927|
|End of Announcement||EQS Group News Service|